Home / Going-concern warnings / Vera Therapeutics, Inc.
Filed 2025-05-07 路 Form 10-Q 路 Accession 0000950170-25-064733 small
Price before filing: $22.01 (2025-05-06 close, split/dividend-adjusted)
Market cap at flag: $1.44B (2025-05-07) 路 Latest: $2.00B (2026-10-16)
| Window | VERA | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | +3.1% | +7.2% | -4.1% | 2025-06-06 |
| 90 days | -6.2% | +12.7% | -18.9% | 2025-08-05 |
| 180 days | +17.9% | +23.0% | -5.1% | 2025-11-03 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
"As a result, these conditions raise substantial doubt about our ability to continue as a going concern over the long-term."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Source: management disclosure in Form 10-Q (period 2025-03-31)
Why this score: quarterly (unaudited) disclosure
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.